High Resolution Optoelectronic Retinal Prosthesis

高分辨率光电视网膜假体

• 批准号: 8091258
• 负责人: DANIEL V PALANKER
• 金额: $ 118.38万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8091258
• 关键词: 3-Dimensional; Acute; Address; Affect; Age related macular degeneration; Animal Model; Behavioral; Biomedical Research; Blindness; Cells; Chronic; Clinical Trials; Computers; Development; Devices; Discrimination; Disease; Electric Stimulation; Electrodes; Electrophysiology (science); Electroretinography; Elements; Engineering; Environment; Etiology; Evaluation; Eye; Eye Movements; Felis catus; Health; Image; Implant; Implanted Electrodes; In Vitro; Light; Lighting; Link; Macular degeneration; Methods; Modeling; Morphology; Neural Retina; Neurons; Operative Surgical Procedures; Ophthalmologist; Optics; Oryctolagus cuniculus; Outcome; Patients; Pattern; Perception; Photoreceptors; Physiologic pulse; Preparation; Prosthesis; Rattus; Resolution; Retina; Retinal; Retinal Ganglion Cells; Retinitis Pigmentosa; Safety; Signal Transduction; Silicon; Staging; Staging System; Structure; System; Systems Development; Techniques; Testing; Thick; Tissues; Vision; Visual; Visual Acuity; Visual Fields; Visual system structure; base; biomaterial compatibility; computerized data processing; design; electric impedance; extracellular; flexibility; image processing; implantation; in vivo; innovation; novel; photoreceptor degeneration; prototype; research study; response; retinal neuron; retinal prosthesis; retinal stimulation; sight for the blind; superior colliculus Corpora quadrigemina; visual information

DESCRIPTION (provided by applicant): The two leading causes of untreatable blindness in the developed world are retinitis pigmentosa (RP) and end-stage macular degeneration (AMD). While the etiology of the diseases varies, they share a common outcome, the degeneration of photoreceptors, the light sensing cells of the retina. One approach to restoring visual function is to stimulate the remaining retinal circuitry using a retinal prosthetic that encodes the visual information into electrical signals. The challenge is to design such a system that interfaces with the diseased retina and provides a high resolution representation of the visual environment. This project brings together a unique combination of engineers, neurobiologists, and ophthalmologists to complete the development and evaluation of a high-resolution retinal prosthetic system designed specifically to achieve functional levels of vision. In this system the processed images of the visual scene are projected by pulsed infrared light onto a subretinally placed microphotodiode array. Photovoltaic pixels in the array convert pulsed light into biphasic pulses of electric current that directly stimulate retinal neurons. This Optoelectronic Retinal Prosthetic System offers several novel and advantageous features: hundreds or thousands of pixels in the implant can be activated simultaneously and independently, simplified surgical procedure, user-adjustable image processing, high resolution stimulation, a natural link between eye movements and image perception, a 3- dimensional implant structure that facilitates close proximity of neurons with stimulating electrodes, and modular design of the implant that allows for expansion of the stimulated field. Such a versatile system could be used to address the divergent needs of RP and AMD patients. Most of the system components have been developed and some aspects tested. Prototype photodiode arrays show long-term biocompatibility, and provide retinal stimulation upon illumination with IR flash. This proposal represents the final two stages of system development in rat and cat models of RP, prior to clinical trials. The proposed experiments will assess: stimulation efficacy and safety limits, long term biocompatibility, and limits of spatial resolution with flat and 3-dimensional implants in electrophysiological and behavioral experiments. PUBLIC HEALTH RELEVANCE: The two leading causes of untreatable blindness in the developed world are retinitis pigmentosa (RP) and end-stage age-related macular degeneration (AMD). Both diseases result in the loss of photoreceptors, while most of the signal processing neurons in the retina are preserved. We propose to restore sight of the blind by delivering visual information to the remaining cells in the neural retina using high resolution electrical stimulation by a photovoltaic subretinal prosthesis. This optoelectronic system represents an innovative and versatile design that addresses the divergent needs of patients with both RP and AMD.

描述（由申请人提供）：在发达国家，无法治愈的失明的两个主要原因是色素性视网膜炎（RP）和终末期黄斑变性（AMD）。虽然这些疾病的病因各不相同，但它们有一个共同的结果，即视网膜上的光感受器（感光细胞）的退化。恢复视觉功能的一种方法是使用将视觉信息编码成电信号的视网膜假体刺激剩余的视网膜回路。挑战在于设计这样一个系统，它与患病的视网膜接口，并提供视觉环境的高分辨率表示。该项目汇集了工程师、神经生物学家和眼科医生的独特组合，以完成高分辨率视网膜假体系统的开发和评估，该系统专门设计用于实现视觉功能水平。在该系统中，经过处理的视觉场景图像通过脉冲红外光投射到视网膜下放置的微光电二极管阵列上。阵列中的光伏像素将脉冲光转换成直接刺激视网膜神经元的双相电流脉冲。这种光电视网膜假体系统提供了几个新颖和有利的特点：植入物中的数百或数千个像素可以同时和独立激活，简化的手术程序，用户可调节的图像处理，高分辨率刺激，眼运动和图像感知之间的自然联系，三维植入物结构，促进神经元与刺激电极的紧密接近，植入物的模块化设计允许扩展刺激场。这种多功能的系统可用于解决RP和AMD患者的不同需求。已经开发了系统的大部分组件，并对某些方面进行了测试。原型光电二极管阵列显示出长期的生物相容性，并在红外闪光灯照射下提供视网膜刺激。该建议代表了RP在大鼠和猫模型中系统发展的最后两个阶段，在临床试验之前。拟议的实验将评估：电生理和行为实验中平面和三维植入物的刺激效果和安全限制，长期生物相容性以及空间分辨率限制。公共卫生相关性：在发达国家，导致无法治愈的失明的两个主要原因是视网膜色素变性（RP）和终末期年龄相关性黄斑变性（AMD）。这两种疾病都会导致光感受器的丧失，而视网膜上的大多数信号处理神经元都被保留了下来。我们建议通过光伏视网膜下假体的高分辨率电刺激将视觉信息传递给神经视网膜中的剩余细胞，从而恢复盲人的视力。这种光电系统代表了一种创新和通用的设计，解决了RP和AMD患者的不同需求。